ArticleNuklearmedizin. Nuclear medicine2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Rudolf Werner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNuklearmedizin. Nuclear medicine2024
Rudolf Werner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.